{
  "nctId": "NCT04199793",
  "briefTitle": "Lavare Cycle in Patients Receiving HeartWare Left Ventricular Assist Device",
  "officialTitle": "Assessment of Lavare Cycle Implementation Among Patients Following HeartWare Left Ventricular Assist Device Implantation: A Prospective Randomized Controlled Pilot Study",
  "protocolDocument": {
    "nctId": "NCT04199793",
    "filename": "Prot_SAP_000.pdf",
    "label": "Study Protocol and Statistical Analysis Plan",
    "date": "2020-08-31",
    "uploadDate": "2022-08-29T12:19",
    "size": 322561,
    "downloadUrl": "https://clinicaltrials.gov/api/v2/studies/NCT04199793/document/Prot_SAP_000.pdf",
    "hasProtocol": true,
    "hasSap": true,
    "hasIcf": false
  },
  "phase": [
    "NA"
  ],
  "studyType": "INTERVENTIONAL",
  "allocation": "RANDOMIZED",
  "interventionModel": "PARALLEL",
  "masking": "NONE",
  "enrollmentInfo": {
    "enrollmentCount": 9,
    "enrollmentType": "ACTUAL"
  },
  "timeline": {
    "startDate": "2020-08-10",
    "completionDate": "2021-08-10",
    "primaryCompletionDate": "2021-08-10",
    "firstSubmitDate": "2019-12-12",
    "firstPostDate": "2019-12-16"
  },
  "eligibilityCriteria": {
    "criteria": "Inclusion Criteria:\n\n1. Age ≥18 years\n2. Approved for or supported with HeartWare durable LVAD\n3. Capable of giving informed consent\n\nExclusion Criteria:\n\n1. For those undergoing new device implantation:\n\n   1. Age \\<18 years\n   2. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) profile 1 at the time of implantation\n   3. Presence of intra-cardiac thrombus\n   4. History of thromboembolic event within previous 3 months of enrollment\n2. For those with prior LVAD implantation with on-going support:\n\n   1. Support duration \\<3 months\n   2. History of prior LVAD pump exchange\n   3. History of LVAD pump hemolysis or thrombosis as defined by INTERMACS criteria\n   4. History of stroke or transient ischemic event within previous 3 months of enrollment\n   5. History of post-LVAD severe right ventricular failure as defined by INTERMACS criteria within previous 3 months of enrollment\n   6. History of pump-related infection treated within previous 3 months of enrollment or those on chronic antibiotics suppressive therapy for pump related infection\n   7. History of post-LVAD intra-cardiac or arterial thrombus or thromboembolic event within previous 3 months of enrollment\n   8. International Normalized Ratio (INR) \\<2 within previous 30-days from the date of enrollment\n   9. Aspirin dose \\<325 mg/day\n   10. Lactate Dehydrogenase (LDH) levels ≥ 3 times the upper normal limit in previous 3 months",
    "healthyVolunteers": false,
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": [
      "ADULT",
      "OLDER_ADULT"
    ]
  },
  "endpoints": {
    "primary": [
      {
        "measure": "Composite Endpoint of Total Ischemic Events, Thromboembolic Events, Pump Hemolysis or Thrombosis, Pump Exchange",
        "description": "INTERMACS definitions of cerebrovascular events, pump hemolysis/ thrombosis will be used. Pump malfunction needing device exchange or emergent transplant will also be included in the main composite event",
        "timeFrame": "6 months"
      }
    ],
    "secondary": [
      {
        "measure": "All-cause Mortality",
        "description": "death from any cause",
        "timeFrame": "6 months"
      },
      {
        "measure": "Survival to Transplantation",
        "description": "Number of days supported on LVAD until transplant",
        "timeFrame": "6 months"
      },
      {
        "measure": "Rehospitalizations",
        "description": "Any cardiac and non-cardiac re-hospitalizations since trial enrollment",
        "timeFrame": "6 months"
      },
      {
        "measure": "Mucosal Bleeding",
        "description": "Epistaxis, gastrointestinal bleeding, urological bleeding events will be analyzed",
        "timeFrame": "6 months"
      },
      {
        "measure": "Right Ventricular Failure",
        "description": "INTERMACS definitions for Right ventricular failure will be analyzed",
        "timeFrame": "6 months"
      },
      {
        "measure": "Device Related Infection",
        "description": "LVAD device systems related infections will be analyzed",
        "timeFrame": "6 months"
      },
      {
        "measure": "Aortic Insufficiency",
        "description": "Echocardiographic evidence will be used to define severity of aortic insufficiency",
        "timeFrame": "6 months"
      },
      {
        "measure": "Change in 6 Minute Walk Test",
        "description": "The 6 Minute Walk Test is a sub-maximal exercise test used to assess aerobic capacity and endurance. The distance covered over a time of 6 minutes is used as the outcome by which to compare changes in performance capacity.",
        "timeFrame": "Baseline to 6 months"
      },
      {
        "measure": "Changes in New York Heart Association Class",
        "description": "Functional class will be assessed at baseline and during follow up to assess improvement in functional status",
        "timeFrame": "Baseline to 6 months"
      },
      {
        "measure": "Quality of Life Measured by The Kansas City Cardiomyopathy Questionnaire",
        "description": "Kansas City Cardiomyopathy Questionnaire is a 23-item, self-administered instrument that quantifies physical function, symptoms (frequency, severity and recent change), social function, self-efficacy and knowledge, and quality of life. The score can range from 0-100, in which higher scores reflect better health status.",
        "timeFrame": "6 months"
      }
    ],
    "other": []
  },
  "complexityMetrics": {
    "eligibilityCriteria": {
      "inclusionCount": 1,
      "exclusionCount": 1,
      "totalCount": 2
    },
    "endpoints": {
      "primaryCount": 1,
      "secondaryCount": 10,
      "otherCount": 0,
      "totalCount": 11
    },
    "studyDesign": {
      "phases": [
        "NA"
      ],
      "isRandomized": true,
      "isMasked": false,
      "interventionModel": "PARALLEL"
    },
    "overallComplexityScore": 74,
    "complexityCategory": "Complex"
  },
  "collectionDate": "2025-09-22T02:29:36.514Z",
  "dataSource": "ClinicalTrials.gov API v2 - Comprehensive Collection"
}